MovDisordV3, Main, Merge, bibRecord, 003D52

Gene transfer therapy for neurodegenerative disorders

Identifieur interne : 003D52 ( Main/Merge ); précédent : 003D51; suivant : 003D53

Gene transfer therapy for neurodegenerative disorders

Auteurs : Andrew Feigin [États-Unis] ; David Eidelberg [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 2007-07-15.

RBID : ISTEX:1462E3FC3D8422AFEE14E9E50B45ED07001A6D25

English descriptors

KwdEn :
- Animals, Gene Transfer Techniques, Genetic Therapy (methods), Humans, Huntington's disease., Neurodegenerative Diseases (classification), Neurodegenerative Diseases (genetics), Neurodegenerative Diseases (therapy), Parkinson's disease, gene therapy, movement disorders.
MESH :
- classification : Neurodegenerative Diseases.
- genetics : Neurodegenerative Diseases.
- methods : Genetic Therapy.
- therapy : Neurodegenerative Diseases.
- Animals, Gene Transfer Techniques, Humans.

Abstract

Recent advances in gene transfer technology have led to promising new therapies for neurodegenerative disorders. This article will review methods of gene transfer therapy and applications of these techniques to both genetic and sporadic neurodegenerative illnesses. The article will focus on Parkinson's disease, Huntington's disease, and Alzheimer's disease. Several promising gene therapy approaches to these diseases are being pursued both in animal models and in early human trials. Initial safety–tolerability results from these trials appear promising. It is therefore likely that the number of human trials of gene therapy for neurodegenerative disorders will increase over the coming years. © 2007 Movement Disorder Society

Url:

https://api.istex.fr/document/1462E3FC3D8422AFEE14E9E50B45ED07001A6D25/fulltext/pdf

DOI: 10.1002/mds.21423

Links to Exploration step

ISTEX:1462E3FC3D8422AFEE14E9E50B45ED07001A6D25

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gene transfer therapy for neurodegenerative disorders</title>
<author><name sortKey="Feigin, Andrew" sort="Feigin, Andrew" uniqKey="Feigin A" first="Andrew" last="Feigin">Andrew Feigin</name>
</author>
<author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1462E3FC3D8422AFEE14E9E50B45ED07001A6D25</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/mds.21423</idno>
<idno type="url">https://api.istex.fr/document/1462E3FC3D8422AFEE14E9E50B45ED07001A6D25/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001E48</idno>
<idno type="wicri:Area/Istex/Curation">001E48</idno>
<idno type="wicri:Area/Istex/Checkpoint">001938</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Feigin A:gene:transfer:therapy</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:17393533</idno>
<idno type="wicri:Area/PubMed/Corpus">002792</idno>
<idno type="wicri:Area/PubMed/Curation">002792</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002802</idno>
<idno type="wicri:Area/Ncbi/Merge">001B47</idno>
<idno type="wicri:Area/Ncbi/Curation">001B47</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001B47</idno>
<idno type="wicri:Area/Main/Merge">003D52</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Gene transfer therapy for neurodegenerative disorders</title>
<author><name sortKey="Feigin, Andrew" sort="Feigin, Andrew" uniqKey="Feigin A" first="Andrew" last="Feigin">Andrew Feigin</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Neurosciences, The Feinstein Institute for Medical Research, North Shore—Long Island Jewish Health System, Manhasset, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Neurosciences, The Feinstein Institute for Medical Research, North Shore—Long Island Jewish Health System, Manhasset, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-07-15">2007-07-15</date>
<biblScope unit="vol">22</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1223">1223</biblScope>
<biblScope unit="page" to="1228">1228</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">1462E3FC3D8422AFEE14E9E50B45ED07001A6D25</idno>
<idno type="DOI">10.1002/mds.21423</idno>
<idno type="ArticleID">MDS21423</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Gene Transfer Techniques</term>
<term>Genetic Therapy (methods)</term>
<term>Humans</term>
<term>Huntington's disease.</term>
<term>Neurodegenerative Diseases (classification)</term>
<term>Neurodegenerative Diseases (genetics)</term>
<term>Neurodegenerative Diseases (therapy)</term>
<term>Parkinson's disease</term>
<term>gene therapy</term>
<term>movement disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Neurodegenerative Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Neurodegenerative Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Genetic Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neurodegenerative Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Gene Transfer Techniques</term>
<term>Humans</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Recent advances in gene transfer technology have led to promising new therapies for neurodegenerative disorders. This article will review methods of gene transfer therapy and applications of these techniques to both genetic and sporadic neurodegenerative illnesses. The article will focus on Parkinson's disease, Huntington's disease, and Alzheimer's disease. Several promising gene therapy approaches to these diseases are being pursued both in animal models and in early human trials. Initial safety–tolerability results from these trials appear promising. It is therefore likely that the number of human trials of gene therapy for neurodegenerative disorders will increase over the coming years. © 2007 Movement Disorder Society</div>
</front>
</TEI>
<double doi="10.1002/mds.21423"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gene transfer therapy for neurodegenerative disorders</title>
<author><name sortKey="Feigin, Andrew" sort="Feigin, Andrew" uniqKey="Feigin A" first="Andrew" last="Feigin">Andrew Feigin</name>
</author>
<author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1462E3FC3D8422AFEE14E9E50B45ED07001A6D25</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/mds.21423</idno>
<idno type="url">https://api.istex.fr/document/1462E3FC3D8422AFEE14E9E50B45ED07001A6D25/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001E48</idno>
<idno type="wicri:Area/Istex/Curation">001E48</idno>
<idno type="wicri:Area/Istex/Checkpoint">001938</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Feigin A:gene:transfer:therapy</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Gene transfer therapy for neurodegenerative disorders</title>
<author><name sortKey="Feigin, Andrew" sort="Feigin, Andrew" uniqKey="Feigin A" first="Andrew" last="Feigin">Andrew Feigin</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Neurosciences, The Feinstein Institute for Medical Research, North Shore—Long Island Jewish Health System, Manhasset, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Neurosciences, The Feinstein Institute for Medical Research, North Shore—Long Island Jewish Health System, Manhasset, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-07-15">2007-07-15</date>
<biblScope unit="vol">22</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1223">1223</biblScope>
<biblScope unit="page" to="1228">1228</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">1462E3FC3D8422AFEE14E9E50B45ED07001A6D25</idno>
<idno type="DOI">10.1002/mds.21423</idno>
<idno type="ArticleID">MDS21423</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Huntington's disease.</term>
<term>Parkinson's disease</term>
<term>gene therapy</term>
<term>movement disorders</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Recent advances in gene transfer technology have led to promising new therapies for neurodegenerative disorders. This article will review methods of gene transfer therapy and applications of these techniques to both genetic and sporadic neurodegenerative illnesses. The article will focus on Parkinson's disease, Huntington's disease, and Alzheimer's disease. Several promising gene therapy approaches to these diseases are being pursued both in animal models and in early human trials. Initial safety–tolerability results from these trials appear promising. It is therefore likely that the number of human trials of gene therapy for neurodegenerative disorders will increase over the coming years. © 2007 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gene transfer therapy for neurodegenerative disorders.</title>
<author><name sortKey="Feigin, Andrew" sort="Feigin, Andrew" uniqKey="Feigin A" first="Andrew" last="Feigin">Andrew Feigin</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Neurosciences, The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York 11030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Neurosciences, The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York 11030</wicri:regionArea>
<wicri:noRegion>New York 11030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="doi">10.1002/mds.21423</idno>
<idno type="RBID">pubmed:17393533</idno>
<idno type="pmid">17393533</idno>
<idno type="wicri:Area/PubMed/Corpus">002792</idno>
<idno type="wicri:Area/PubMed/Curation">002792</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002802</idno>
<idno type="wicri:Area/Ncbi/Merge">001B47</idno>
<idno type="wicri:Area/Ncbi/Curation">001B47</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001B47</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Gene transfer therapy for neurodegenerative disorders.</title>
<author><name sortKey="Feigin, Andrew" sort="Feigin, Andrew" uniqKey="Feigin A" first="Andrew" last="Feigin">Andrew Feigin</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Neurosciences, The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York 11030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Neurosciences, The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York 11030</wicri:regionArea>
<wicri:noRegion>New York 11030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Gene Transfer Techniques</term>
<term>Genetic Therapy (methods)</term>
<term>Humans</term>
<term>Neurodegenerative Diseases (classification)</term>
<term>Neurodegenerative Diseases (genetics)</term>
<term>Neurodegenerative Diseases (therapy)</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Neurodegenerative Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Neurodegenerative Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Genetic Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neurodegenerative Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Gene Transfer Techniques</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Recent advances in gene transfer technology have led to promising new therapies for neurodegenerative disorders. This article will review methods of gene transfer therapy and applications of these techniques to both genetic and sporadic neurodegenerative illnesses. The article will focus on Parkinson's disease, Huntington's disease, and Alzheimer's disease. Several promising gene therapy approaches to these diseases are being pursued both in animal models and in early human trials. Initial safety-tolerability results from these trials appear promising. It is therefore likely that the number of human trials of gene therapy for neurodegenerative disorders will increase over the coming years.</div>
</front>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D52 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003D52 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:1462E3FC3D8422AFEE14E9E50B45ED07001A6D25
   |texte=   Gene transfer therapy for neurodegenerative disorders
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Gene transfer therapy for neurodegenerative disorders

Gene transfer therapy for neurodegenerative disorders

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.